🔗 Permalink

Inventor profile of:

STEFAN ANKER

City:

BERLIN

Country:

Germany

Published Applications:

Last publication date:

2024-10-03

Top Assignees for applications by STEFAN ANKER

The entities that hold a legal rights for patent applications filed by inventor ANKER STEFAN:

Actimed Therapeutics Limited 5 Ascot, United Kingdom
Stefan Anker 2 Berlin, Germany
B.R.A.H.M.S. GMBH 2 Henningsdorf, Germany
Actimed Therapeutics LTD 2 Ascot, United Kingdom
PAR PHARMACEUTICALS, INC. 2 SPRING VALLEY, NY United States
B.R.A.H.M.S. AG 1 Henningsdorf, Germany
B.R.A.H.M.S. AG 1 Hennigsdorf, Germany
BRAHMS AKTIENGESELLSCHAFT 1 Henningsdorf, Germany
MAX-DELBRUECK-CENTRUM FUR MOLEKULARE MEDIZIN 1 Berlin, Germany
CHARITÉ—UNIVERSITAETSMEDIZN BERLIN 1 Berlin, Germany
Actimed Therapeutics Limited 1 Ascot Berkashire, United Kingdom
ACTIMED THERAPEUTICS LTD 1 Berkshire, United Kingdom
PSIOXUS THERAPEUTICS LIMITED 1 London, United Kingdom
PsiOxus Therapeutics Limited 1 London, United Kingdom
Dr. Stefan ANKER 1 Berlin, Germany
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN 1 BERLIN, Germany

Recent patent applications by ANKER STEFAN

STEFAN ANKER from BERLIN, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-03

US20240325322A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

#2 | 2021-11-11

US20210346320A1

Human necessities

S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING MUSCLE WEAKNESS

#3 | 2021-10-28

US20210330615A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

#4 | 2021-08-19

US20210251924A1

Human necessities

Oxprenolol compositions for treating cancer

#5 | 2020-07-23

US20200230080A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating muscle weakness

#6 | 2020-02-20

US20200054585A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

#7 | 2019-02-21

US20190054043A1

Human necessities

Oxprenolol compositions for treating cancer

#8 | 2019-02-14

US20190046476A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating muscle weakness

#9 | 2016-06-23

US20160175286A1

Human necessities

Selective AT2 receptor agonists for use in treatment of cachexia

#10 | 2016-04-14

US20160101117A1

Human necessities

Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency

#11 | 2016-01-28

US20160022613A1

Human necessities

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

#12 | 2016-01-28

US20160022612A1

Human necessities

Oxprenolol compositions for treating cancer

#13 | 2013-10-10

US20130267797A1

Human necessities

Method for enhancing the performance and general condition of a subject

#14 | 2013-06-06

US20130143848A1

Human necessities

USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY

#15 | 2012-04-19

US20120095070A1

Human necessities

Prevention and treatment of sarcopenia

#16 | 2010-11-11

US20100285493A1

Physics

Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease

#17 | 2010-06-10

US20100143953A1

Physics

Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients

#18 | 2009-10-01

US20090248101A1

Human necessities

Method for enhancing the performance and general condition of a subject

#19 | 2009-08-06

US20090197851A1

Human necessities

THERAPY AND USE OF COMPOUNDS IN THERAPY

#20 | 2008-10-30

US20080269179A1

Human necessities

Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary Diseases

#21 | 2008-06-12

US20080139521A1

Human necessities

Use of megestrol acetate for improving heart function and the treatment of heart insufficiency

#22 | 2007-08-23

US20070197485A1

Human necessities

Therapy and Use of Compounds in Therapy

InventorID:

275977 ⎘